Merck's Keytruda continues its string of blockbuster results, but BMS' Opdivo still leads in sales
At the American Society of Clinical Oncology (ASCO) annual meeting over the weekend, Merck's Keytruda continued its winning streak.
Meet "the connectors" as four of the best-regarded medical science liaisons and the leader of the MSL Society discuss what they do, how they do it, and why their work ...
Why Sanofi felt "obligated" to respond to Roseanne Barr's claim of "Ambien tweeting."
The drugmaker clapped back to Roseanne Barr's comment that she was "Ambien tweeting" when she made racist remarks about Valerie Jarrett.